Aug 11 (Reuters) - ImmunoPrecise
* ImmunoPrecise signs definitive agreement with U-Protein
* ImmunoPrecise Antibodies - under terms of definitive agreement, company acquires all of issued and outstanding shares of U-Protein for EUR 6.83 million
* ImmunoPrecise Antibodies - as per deal, co will also appoint Martin Hessing, who is one of principal shareholders of U-Protein, to its board